Progesterone Elicits an Inhibitory Effect upon LPS-Induced Innate Immune Response in Pre-Labor Human Amniotic Epithelium

American Journal of Reproductive Immunology

Volumn 71, Issue 1, 2014, Pages 61-72

  Flores Espinosa, Pilar ^a,c   Pineda Torres, Montzerrat ^a   Vega Sánchez, Rodrigo ^a   Estrada Gutiérrez, Guadalupe ^a   Espejel Nuñez, Aurora ^a   Flores Pliego, Arturo ^a   Maida Claros, Rolando ^a   Paredes Vivas, Yuriria ^a   Morales Méndez, Iyari ^a   Sosa González, Irma ^a   Chávez Mendoza, Angel ^b   Zaga Clavellina, Verónica ^a  

^a INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Chorioamnionitis; Human amniotic epithelium; Inflammation; Innate immunity; Progesterone; TLR 4

Indexed keywords

BETA DEFENSIN 2; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MIFEPRISTONE; MYELOID DIFFERENTIATION FACTOR 88; PROGESTERONE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BETA DEFENSIN; CYTOKINE; DEFB4A PROTEIN, HUMAN; HORMONE ANTAGONIST; TLR4 PROTEIN, HUMAN;

ADULT; AMNION CELL; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EXPLANT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; AMNION; CELL CULTURE; CYTOLOGY; EPITHELIUM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; PREGNANCY;

AMNION; BETA-DEFENSINS; CELLS, CULTURED; CYTOKINES; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION; HORMONE ANTAGONISTS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MIFEPRISTONE; MYELOID DIFFERENTIATION FACTOR 88; PREGNANCY; PROGESTERONE; TOLL-LIKE RECEPTOR 4;

EID: 84890144045     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12163     Document Type: Article

References (68)

1. Szekeres-Bartho J: Immunological relationship between the mother and the fetus. Int Rev Immunol 2002; 21:471-495.
2. Koga K, Mor G: Expression and function of toll-like receptors at the maternal-fetal interface. Reprod Sci 2008; 15:231-242.
3. Malak TM, Ockleford CD, Bell SC, Dalgleish R, Bright N, Macvicar J: Confocal immunofluorescence localization of collagen types I, III, IV, V and VI and their ultrastructural organization in term human fetal membranes. Placenta 1993; 14:385-406.
4. Romero R, Mazor M, Wu YK, Sirtori M, Oyarzun E, Mitchell MD, Hobbins JC: Infection in the pathogenesis of preterm labor. Semin Perinatol 1988; 12:262-279.
5. Romero R, Roslansky P, Oyarzun E, Wan M, Emamian M, Novitsky TJ, Gould MJ, Hobbins JC: Labor and infection. II. Bacterial endotoxin in amniotic fluid and its relationship to the onset of preterm labor. Am J Obstet Gynecol 1988; 158:1044-1049.
6. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM: A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998; 179:186-193.
7. Clark DA, Foerster K, Fung L, He W, Lee L, Mendicino M, Markert UR, Gorczynski RM, Marsden PA, Levy GA: The fgl2 prothrombinase/fibroleukin gene is required for lipopolysaccharide-triggered abortions and for normal mouse reproduction. Mol Hum Reprod 2004; 10:99-108.
8. Foerster K, He W, Manuel J, Bartczak A, Liu M, Markert UR, Levy GA, Clark DA: LPS-induced occult loss in mice requires FGL2. Am J Reprod Immunol 2007; 58:524-529.
9. Stites DP, Siiteri PK: Steroids as immunosuppressants in pregnancy. Immunol Rev 1983; 75:117-138.
10. Miyaura H, Iwata M: Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 2002; 168:1087-1094.
11. Butts CL, Shukair SA, Duncan KM, Bowers E, Horn C, Belyavskaya E, Tonelli L, Sternberg EM: Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. Int Immunol 2007; 19:287-296.
12. Butts CL, Bowers E, Horn JC, Shukair SA, Belyavskaya E, Tonelli L, Sternberg EM: Inhibitory effects of progesterone differ in dendritic cells from female and male rodents. Gend Med 2008; 5:434-447.
13. Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002; 20:197-216.
14. Patni S, Wynen LP, Seager AL, Morgan G, White JO, Thornton CA: Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term. Biol Reprod 2009; 80:243-248.
15. Kim YM, Romero R, Chaiworapongsa T, Kim GJ, Kim MR, Kuivaniemi H, Tromp G, Espinoza J, Bujold E, Abrahams VM, Mor G: Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol 2004; 191:1346-1355.
16. Adams KM, Lucas J, Kapur RP, Stevens AM: LPS induces translocation of TLR4 in amniotic epithelium. Placenta 2007; 28:477-4781.
17. Adams Waldorf KM, Persing D, Novy MJ, Sadowsky DW, Gravett MG: Pretreatment with toll-like receptor 4 antagonist inhibits lipopolysaccharide-induced preterm uterine contractility, cytokines, and prostaglandins in rhesus monkeys. Reprod Sci 2008; 15:121-127.
18. Elovitz MA, Wang Z, Chien EK, Rychlik DF, Phillippe M: A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am J Pathol 2003; 163:2103-2111.
19. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085-2088.
20. Underhill DM, Ozinsky A: Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002; 14:103-110.
21. King A, Paltoo A, Kelly R, Sallenave J, Bocking A, Challis J: Expression of natural antimicrobials by human placenta and fetal membranes. Placenta 2007; 28:161-169.
22. Raghupathy R: Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18:478-482.
23. Yoon BH, Romero R, Park JS, Chang JW, Kim YA, Kim JC, Kim KS: Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 1998; 179:1254-1260.
24. Kim MJ, Romero R, Gervasi MT, Kim JS, Yoo W, Lee DC, Mittal P, Erez O, Kusanovic JP, Hassan SS, Kim CJ: Widespread microbial invasion of the chorioamniotic membranes is a consequence and not a cause of intra-amniotic infection. Lab Invest 2009; 89:924-936.
25. Zaga V, Estrada-Gutierrez G, Beltran-Montoya J, Maida-Claros R, Lopez-Vancell R, Vadillo-Ortega F: Secretions of interleukin-1beta and tumor necrosis factor alpha by whole fetal membranes depend on initial interactions of amnion or choriodecidua with lipopolysaccharides or group B streptococci. Biol Reprod 2004; 7:1296-1302.
26. Garcia-Lopez G, Flores-Espinosa P, Zaga-Clavellina V: Tissue-specific human beta-defensins (HBD)1, HBD2, and HBD3 secretion from human extra-placental membranes stimulated with Escherichia coli. Reprod Biol Endocrinol 2010; 8:146.
27. Astle S, Slater DM, Thornton S: The involvement of progesterone in the onset of human labour. Eur J Obstet Gynecol Reprod Biol 2003; 108:177-1781.
28. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH: Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357:462-469.
29. Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, Vijayaraghavan J, Trivedi Y, Soma-Pillay P, Sambarey P, Dayal A, Potapov V, O'Brien J, Astakhov V, Yuzko O, Kinzler W, Dattel B, Sehdev H, Mazheika L, Manchulenko D, Gervasi MT, Sullivan L, Conde-Agudelo A, Phillips JA, Creasy GW: Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011; 38:18-31.
30. Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O'Brien JM, Cetingoz E, Da Fonseca E, Creasy GW, Klein K, Rode L, Soma-Pillay P, Fusey S, Cam C, Alfirevic Z, Hassan SS: Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 2012; 206:124.e1-124.e19.
31. Aisemberg J, Vercelli CA, Bariani MV, Billi SC, Wolfson ML, Franchi AM: Progesterone is essential for protecting against LPS-induced pregnancy loss. LIF as a potential mediator of the anti-inflammatory effect of progesterone. PLoS ONE 2013; 8:e56161.
32. Jones LA, Anthony JP, Henriquez FL, Lyons RE, Nickdel MB, Carter KC, Alexander J, Roberts CW: Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors. Immunology 2008; 125:59-69.
33. Su L, Sun Y, Ma F, Lü P, Huang H, Zhou J: Progesterone inhibits Toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-kappaB activation and enhancing SOCS1 expression. Immunol Lett 2009; 125:151-155.
34. Harju K, Ojaniemi M, Rounioja S, Glumoff V, Paananen R, Vuolteenaho R, Hallman M: Expression of toll-like receptor 4 and endotoxin responsiveness in mice during perinatal period. Pediatr Res 2005; 57:644-648.
35. Elovitz MA, Mrinalini C: Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation? Am J Obstet Gynecol 2005; 193:1149-1155.
36. Fukuyama A, Tanaka K, Kakizaki I, Kasai K, Chiba M, Nakamura T, Mizunuma H: Anti-inflammatory effect of proteoglycan and progesterone on human uterine cervical fibroblasts. Life Sci 2012; 90:484-488.
37. Srivastava MD, Thomas A, Srivastava BI, Check JH: Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone. Leuk Lymphoma 2007; 48:1610-1617.
38. Zhang JP, Yang Y, Levy O, Chen C: Human neonatal peripheral blood leukocytes demonstrate pathogen-specific coordinate expression of TLR2, TLR4/MD2, and MyD88 during bacterial infection in vivo. Pediatr Res 2010; 68:479-483.
39. Yu X, Xiao CJ, Dai HM, Wang W, Meng J, Zhang XT, Ning Q, Luo XP: Effect of intrauterine lipopolysaccharide infusion on Toll-like receptor 4 signaling transduction pathway in lungs of perinatal rats. Zhonghua Er Ke Za Zhi 2009; 47:667-671.
40. Bowie A, O'Neill LA: The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol 2000; 67:508-514.
41. Giannoni E, Guignard L, Knaup Reymond M, Perreau M, Roth-Kleiner M, Calandra T, Roger T: Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns. Infect Immun 2011; 79:2690-2698.
42. Menon R, Peltier MR, Eckardt J, Fortunato SJ: Diversity in cytokine response to bacteria associated with preterm birth by fetal membranes. Am J Obstet Gynecol 2009; 201 306.e1-306.e6.
43. Holcberg G, Amash A, Sapir O, Sheiner E, Levy S, Huleihel M: Perfusion with lipopolysaccharide differently affects the secretion of tumor necrosis factor-alpha and interleukin-6 by term and preterm human placenta. J Reprod Immunol 2007; 74:15-23.
44. Miller L, Hunt JS: Sex steroid hormones and macrophage function. Life Sci 1996; 59:1-14.
45. Cobo T, Palacio M, Navarro-Sastre A, Ribes A, Bosch J, Filella X, Gratacós E: Predictive value of combined amniotic fluid proteomic biomarkers and interleukin-6 in preterm labor with intact membranes. Am J Obstet Gynecol 2009; 200:499.e1-499.e6.
46. Sorokin Y, Romero R, Mele L, Wapner RJ, Iams JD, Dudley DJ, Spong CY, Peaceman AM, Leveno KJ, Harper M, Caritis SN, Miodovnik M, Mercer BM, Thorp JM, O'Sullivan MJ, Ramin SM, Carpenter MW, Rouse DJ, Sibai B: Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32 weeks and adverse neonatal outcomes. Am J Perinatol 2010; 27:631-640.
47. Reisenberger K, Egarter C, Knöfler M, Schiebel I, Gregor H, Hirschl AM, Heinze G, Husslein P: Cytokine and prostaglandin production by amnion cells in response to the addition of different bacteria. Am J Obstet Gynecol 1998; 178:50-53.
48. Reisenberger K, Egarter C, Schiebel I, Obermair A, Kiss H, Lehner R: In vitro cytokine and prostaglandin production by amnion cells in the presence of bacteria. Am J Obstet Gynecol 1997; 176:981-984.
49. Zaga-Clavellina V, Garcia-Lopez G, Flores-Herrera H, Espejel-Nuñez A, Flores-Pliego A, Soriano-Becerril D, Maida-Claros R, Merchant-Larios H, Vadillo-Ortega F: In vitro secretion profiles of interleukin (IL)-1beta, IL-6, IL-8, IL-10, and TNF alpha after selective infection with Escherichia coli in human fetal membranes. Reprod Biol Endocrinol 2007; 5:46.
50. Zaga-Clavellina V, Martha RV, Flores-Espinosa P: In vitro secretion profile of pro-inflammatory cytokines IL-1β, TNF-α, IL-6, and of human beta-defensins (HBD)-1, HBD-2, and HBD-3 from human chorioamniotic membranes after selective stimulation with Gardnerella vaginalis. Am J Reprod Immunol 2012; 67:34-43.
51. Zaga-Clavellina V, López GG, Estrada-Gutierrez G, Martinez-Flores A, Maida-Claros R, Beltran-Montoya J, Vadillo-Ortega F: Incubation of human chorioamniotic membranes with Candida albicans induces differential synthesis and secretion of interleukin-1beta, interleukin-6, prostaglandin E, and 92 kDa type IV collagenase. Mycoses 2006; 49:6-13.
52. Anbe H, Okawa T, Sugawara N, Takahashi H, Sato A, Vedernikov YP, Saade GR, Garfield RE: Influence of progesterone on myometrial contractility in pregnant mice treated with lipopolysaccharide. J Obstet Gynaecol Res 2007; 33:765-771.
53. Gotkin JL, Celver J, McNutt P, Shields AD, Howard BC, Paonessa DJ, Napolitano PG: Progesterone reduces lipopolysaccharide induced interleukin-6 secretion in fetoplacental chorionic arteries, fractionated cord blood, and maternal mononuclear cells. Am J Obstet Gynecol 2006; 195:1015-1019.
54. Romero R, Ceska M, Avila C, Mazor M, Behnke E, Lindley I: Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol 1991; 165:813-820.
55. Park JS, Park CW, Lockwood CJ, Norwitz ER: Role of cytokines in preterm labor and birth. Minerva Ginecol 2005; 57:349-366.
56. Loudon JA, Elliott CL, Hills F, Bennett PR: Progesterone represses interleukin-8 and cyclo-oxygenase-2 in human lower segment fibroblast cells and amnion epithelial cells. Biol Reprod 2003; 69:331-337.
57. Dealtry GB, O'Farrell MK, Fernandez N: The Th2 cytokine environment of the placenta. Int Arch Allergy Immunol 2000; 123:107-119.
58. Trautman MS, Collmer D, Edwin SS, White W, Mitchell MD, Dudley DJ: Expression of interleukin-10 in human gestational tissues. J Soc Gynecol Investig 1997; 4:247-253.
59. Simpson KL, Keelan JA, Mitchell MD: Labor-associated changes in interleukin-10 production and its regulation by immunomodulators in human choriodecidua. J Clin Endocrinol Metab 1998; 83:4332-4337.
60. Robertson SA, Skinner RJ, Care AS: Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol 2006; 177:4888-4896.
61. Shields AD, Wright J, Paonessa DJ, Gotkin J, Howard BC, Hoeldtke NJ, Napolitano PG: Progesterone modulation of inflammatory cytokine production in a fetoplacental artery explant model. Am J Obstet Gynecol 2005; 193:1144-1148.
62. Stock SJ, Kelly RW, Riley SC, Calder AA: Natural antimicrobial production by the amnion. Am J Obstet Gynecol 2007; 196:255.e1-255.e6.
63. Han JH, Kim MS, Lee MY, Kim TH, Lee MK, Kim HR, Myung SC: Modulation of human beta-defensin-2 expression by 17beta-estradiol and progesterone in vaginal epithelial cells. Cytokine 2010; 49:209-214.
64. Mahajan DK, London SN: Mifepristone (RU486): a review. Fertil Steril 1997; 68:967-976.
65. Merlino A, Welsh T, Erdonmez T, Madsen G, Zakar T, Smith R, Mercer B, Mesiano S: Nuclear progesterone receptor expression in the human fetal membranes and decidua at term before and after labor. Reprod Sci 2009; 6:357-363.
66. Patel FA, Funder JW, Challis JR: Mechanism of cortisol/progesterone antagonism in the regulation of 15-hydroxyprostaglandin dehydrogenase activity and messenger ribonucleic acid levels in human chorion and placental trophoblast cells at term. J Clin Endocrinol Metab 2003; 88:2922-2933.
67. Goldman S, Weiss A, Almalah I, Shalev E: Progesterone receptor expression in human decidua and fetal membranes before and after contractions: possible mechanism for functional progesterone withdrawal. Mol Hum Reprod 2005; 11:269-277.
68. Sun K, Myatt L: Enhancement of glucocorticoid-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by proinflammatory cytokines in cultured human amnion fibroblasts. Endocrinology 2003; 144:5568-5577.